Your browser doesn't support javascript.
loading
Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer.
Lin, Qingxiang; Serratore, Andrea; Perri, Jonathan; Roy Chaudhuri, Tista; Qu, Jun; Ma, Wen Wee; Kandel, Eugene S; Straubinger, Robert M.
Affiliation
  • Lin Q; Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Serratore A; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Perri J; New York State Center of Excellence in Bioinformatics & Life Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Roy Chaudhuri T; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Qu J; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Ma WW; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Kandel ES; New York State Center of Excellence in Bioinformatics & Life Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Straubinger RM; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
Br J Pharmacol ; 181(9): 1383-1403, 2024 May.
Article in En | MEDLINE | ID: mdl-37994108
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Limits: Humans Language: En Journal: Br J Pharmacol Year: 2024 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Limits: Humans Language: En Journal: Br J Pharmacol Year: 2024 Type: Article Affiliation country: United States